Volume 95 Issue 38 | p. 13 | Concentrates
Issue Date: September 25, 2017

Catalent acquires Cook Pharmica

By Ryan Cross
Department: Business
Keywords: Mergers & acquisitions, drugs

In a further consolidation of the contract drug-making industry, Catalent is purchasing Cook Pharmica and its 80,000-m2 facility in Bloomington, Ind., for $950 million. Catalent will pay $750 million cash when the deal closes, with the remainder delivered in four annual installments. The acquisition will bolster Catalent’s cell culture manufacturing and also biologics development, manufacturing, and packaging programs.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment